Allison RS, Wynne CJ, Stevenson DS, Tichener G. Carcinoma of the glottic larynx: the Christchurch experience. New
    Zealand Medical Journal 1992;105:256-257.

Altman DG. Analysis of survival times. Practical statistics for medical research. London: Chapman and Hall; 1991:
    Chapter 13, 365-395.

American Cancer Society. Facts on Cancer of the Larynx. ACS Publication No. 2631. 1987.

Austin, DF. Larynx. Schottenfeld D, Fraumeni JF Jr. Cancer Epidemiology and Prevention, Philadelphia: W.B. Saunders
    Company; 1982:554-563.

Barra S, Talamini R, Proto E, Bidoli E, Puxeddu P, Franceschi S. Survival analysis of 378 surgically treated cases of laryngeal
    carcinoma in South Sardinia. Cancer 1990;65:2521-2527.

Bitstream, Inc. Harvard Graphics 3.0. California: Software Publishing Corporation; 1991.

Böck M, Grevers G, Koblitz M, Heim MU, Mempel W. Influence of blood transfusion on recurrence, survival and
    postoperative infections of laryngeal cancer. Acta of Otolaryngology 1990;110:155-160.

Bosch A, Kademian MT, Frias ZC, Caldwell WL. Failures after irradiation in early vocal cord cancer. Laryngoscope

Brandenburg JH, Kellerman G. Aryl hydrocarbon hydroxylase inducibility in laryngeal carcinoma. Archive of
    Otolaryngology 1978;104(3):151-152.

Bravo MP, Espinosa J, del Rey Calero J. Occupational risk factors for cancer of the larynx in Spain. Neoplasma

Capocaccia R, Micheli A, Berrino F, Gatta G, Sant M, Ruzza MR et al. Time trends of lung and larynx cancer in Italy.
    International Journal of Cancer 1994;57:154-161.

Chacko DC, Hendrickson FR, Fisher A. Definitive irradiation of T1-T4N0 larynx cancer. Cancer 1983;51:994-1000.

Collett D. Modeling Survival Data in Medical Research. London: Chapman and Hall; 1994.

Cox DR. Regression models and life tables. Journal of the Royal  Statistical Society 1972;34:187-202.

Daly CJ, Strong EW. Carcinoma of the glottic larynx. The American Journal of Surgery 1975;130:489-493.

Decoufle P. Cancer risks associated with employment in the leather and leather products industry. Archives of
    Environmental Health 1979;34:33-37.

Departamento de Salud. Programa de Control del Cáncer, Registro Central de Cáncer de Puerto Rico. Cáncer en Puerto
    Rico 1991. San Juan;  Noviembre, 1993.

Espinosa J, Bravo P, Baron MG. Influence of tobacco on laryngeal carcinoma in Spain. Neoplasma 1992;39(5):319-322.

Estève J, Benamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further
    discussion.  Statistical Medicine 1990;9:529-538.

Flanders WD, Cann CI, Rothman KJ, Fried MP. Work related risk factors for laryngeal cancer. American Journal of
    Epidemiology 1984;119(1):23-32.

Flanders WD, Rothman KJ. Occupational risk for laryngeal cancer. American Journal of Public Health 1982;72(4):369-372.

Futrell JW, Bennett SH, Hoye RC, Roth JA, Ketchman AS. Predicting survival in cancer of the larynx or hypopharynx. The
    American Journal of Surgery 1971;122:451-457.

Graeber GM, Oates RP, Reed GF. Recurrence as a mode of determining efficacy in treatment of carcinoma of the larynx.
    Laryngoscope 1978;88:1846-1854.

Guenel P, Engholm G, Lynge E. Laryngeal cancer in Denmark: a nationwide longitudinal study based on register linkage data.
    British Journal of Industrial Medicine 1990;47:473-479.

Harris EK, Albert A. Survivorship analysis for clinical studies. New York: Marcel Dekker, Inc.; 1991.

Harwood AR, Bryce DP, Rider WD. Management of T3 glottic cancer. Archives of Otolaryngology 1980;106:697-699.

Harwood AR, Deboer G, Kazim F. Prognostic factors in T3 glottic cancer. Cancer 1981;47:367-372.

Hinds MW, Thomas DB, O'Reilly HP. Asbestos, dental x?rays, tobacco, and alcohol in the epidemiology of laryngeal cancer.
    Cancer 1979;44(3):1114-1120.

Hiranandani LH. Panel epidemiology and etiology of laryngeal carcinoma. Laryngoscope 1975;85:1197-1207.

Hollinshead AC, Lee O, Chretien PB, et al. Antibodies to herpes virus nonvirion antigens in squamous carcinomas. Science

Howell-Burke D, Peters LJ, Goepfert H, Oswald MJ. T2 glottic cancer: recurrence, salvage, and survival after definitive
    radiotherapy. Archives of Otolaryngology and Head and Neck Surgery 1990;116:830-835.

Huygen PLM, Van Den Broek P, Kazem I. Age and mortality in laryngeal cancer. Clinical Otolaryngology 1980;5:129-137.

Iwamoto H. An epidemiological study of laryngeal cancer in Japan (1960-1969). Laryngoscope 1975;85:1162-1172.

Jose B, Mohammed A, Calhoun DL, Tobin DA, Scott RM. Management of early glottic cancer. Journal of Surgical
    Oncology 1981;17:163-168.

Kaplan MJ, Johns ME, Fitz-Hugh GS, Boyd JC, McLean WC, Clark DA et al. Stage II glottic carcinoma: prognostic factors
    and management. Laryngoscope 1983;93:725-728.

Kaplan MJ, Johns ME, Clark DA, Cantrell RW. Glottic carcinoma. The roles of surgery and irradiation. Cancer

Lee NK, Goepfert H, Wendt CD. Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson Cancer
    Center Experience with combined therapy. Laryngoscope 1990;100:831-836.

Levendag PC, Ravasz LA, Terhaard CHJ, Hordijk GJ. T3 squamous cell carcinoma of the larynx treated by a split-course radiation protocol. American Journal of Clinical Oncology 1993;16(6):509-518.

Lindeløv B, Hansen HS. Advanced squamous cell carcinoma of the larynx. Acta Oncologica 1990;29:505-508.

Maceri DR, Lampe HB, Makielski KH, Passamani PP, Krause CJ. Conservation laryngeal surgery. A critical analysis.
    Archives of Otolaryngology 1985;111:361-365.

Maier H, Gewelke U, Dietz A, Heller WD. Risk factors of cancer of the larynx: results of the Heidelberg case-control study.
    Otolaryngology-Head and Neck Surgery 1992;107:577-582.

Mantravadi RVP, Liebner EJ, Haas RE, Skolnik EM, Applebaum EL. Cancer of the glottis: prognostic factors en radiation
    therapy. Radiology 1983;149:311-314.

Matthews DE, Farewell VT. Using and Understanding Medical Statistics. Switzerland: Karger Basel; 1988.

Meredith APDE, Randall CJ, Shaw HJ. Advanced laryngeal cancer: a  management perspective. The Journal of
    Laryngology and Otology 1987;101:1046-1054.

Morgan RW, Shettigara PT. Occupational asbestos exposure, smoking, and laryngeal carcinoma. Annals of the New York
    Academy of Sciences 1976;271:308-310.

Myers EM, editor. Diagnosis. Head and Neck Oncology: Diagnosis, Treatment and Rehabilitation. Boston: Little,
    Brown and Company; 1991:1-125.

McGavran MH, Bauer WC, Ogura JH. The incidence of cervical lymph node metastases from epidermoid carcinoma of the
    larynx and their relationship to certain characteristics of the primary tumor:  A study based on the clinical and pathological
    findings for 96 patients treated by primary en bloc laryngectomy and radical neck dissection. Cancer 1961;14:55-66.

McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival. Tradeoffs between quality and quantity of life in laryngeal
    cancer. The New England Journal of Medicine 1981;305(17):982-987.

Nikolaou A, Fountzillas G, Kosmidis P, Banis C, Sobolos K et al. Laryngeal preservation in cases of advanced laryngeal
    cancer treated with platinum based induction chemotherapy before local treatment. The Journal of Laryngology and
    Otology 1991;105:930-933.

Núñez de Ortega R. Dígalo bien... que nada le cuesta, Guaynabo: Editorial Santillana, Inc.; 1992.

Olsen J, Sabroe S. Occupational causes of laryngeal cancer. Journal of Epidemiology and Community Health

Pera E, Moreno A, Galindo L. Prognostic Factors in Laryngeal Carcinoma, A Multifactorial Study of 416 Cases. Cancer 1986;58:928-934.

Pfister DG, Strong E, Harrison L, Haines IE, Pfister DA, Sessions R et al. Larynx preservation with combined chemotherapy
    and radiation therapy in advanced but resectable head and neck cancer. Journal of Clinical Oncology

Piccirillo JF, Sasaki CT, Wells CK, Feinstein AR. New clinical severity staging system for cancer of the larynx.  Five-year
    survival rates. Annals of Otology, Rhinology and Laryngology 1994;103:83-92.

Pradier R, González A, Matos E, Loria D, Adan R, Saco P et al. Prognostic factors in laryngeal carcinoma, experience in 296
    male patients. Cancer 1993;71:2472-2476.

Price LA, Shaw HJ, Hill BT. Larynx preservation after initial non-cisplatin containing combination chemotherapy plus
    radiotherapy, as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and
    neck cancer: final analysis after 12 years follow-up. The Journal of Laryngology and Otology 1993;107:211-216.

Reddy KTV, Vinayak BC, Jefferis AF, Wallace M. Primary radiotherapy for treating all laryngeal cancer: a district hospital
    experience. The Journal of Laryngology and Otology 1993;107:434-436.

Robertson AG, Boyle P, Yosef HM, Gillis GR, Flatman GE. Cancer of larynx in west of Scotland.  A review of results and a
    consideration of new therapeutic approaches. American Journal of Clinical Oncology 1982;5:527-533

Robin PE, Reid A, Powell DJ, McConkey CC. The incidence of cancer of the larynx. Clinical Otolaryngology

Robin PE, Rockley T, Powell DJ, Reid A. Survival of cancer of the larynx related to treatment. Clinical Otolaryngology

Rockley TR, Robin PE, Powell J, McConkey CC. Primary treatment of cancer of the larynx. The Journal of Laryngology
    and Otology 1991;105:459-462.

Rosario Rosado, RV. Análisis comparativo de supervivencia en cáncer de páncreas en la población de Puerto Rico
    durante los períodos de 1970-74 y 1980-84. Escuela Graduada de Salud Pública. Tesis no publicada requisito para el
    grado de Maestría en Ciencias en Epidemiología.  Recinto de Ciencias Médicas, Universidad de Puerto Rico, Río Piedras,
    Puerto Rico, Octubre 1991.

Rothman KJ, Cann CI, Flanders D, Fried MP. Epidemiology of laryngeal cancer. Epidemiologic Reviews 1980;2:195-209.

Sandberg N, Mercke C, Turesson I. Glottic laryngeal carcinoma with fixed vocal cord treated with full-dose radiation, total
    laryngectomy or combined treatment. Acta Oncologica 1990;29:509-511.

SAS Institute, Inc. SAS User's Guide: Statistics, Version 5 Edition. Cary: SAS Institute, Inc.; 1985.

SAS Institute, Inc. SAS User's Guide: Basics, Version 6. Third edition. Cary: SAS Institute, Inc.; 1990.

SAS Institute, Inc. SAS User's Guide: Statistics, Version 6. Third edition. Cary: SAS Institute, Inc.; 1990.

Schottenfeld D, Fraumeni JF Jr. Cancer Epidemiology and Prevention, Philadelphia: W.B. Saunders Company; 1982.

Shettigara PT, Morgan RW. Asbestos, smoking, and laryngeal carcinoma. Archives of Environmental Health

Silverberg E., Lubera JA. A review of American Cancer Society estimates of cancer cases and deaths. Cancer 1983;33:2.

Small W, Mittal BB, Brand WN, Shetty RM, Rademaker AW, Beck GG et al. Results of radiation therapy in early glottic
    carcinoma: multivariate analysis of prognostic and radiation therapy variables. Radiology 1992;183:789-794.

Soo KC, Shah JP, Gopinath KS, Gerold FP, Jaques DP, Strong EW. Analysis of prognostic variables and results after
    supraglottic partial laryngectomy. The American Journal of Surgery 1988;156:301-305.

Soo KC, Shah JP, Gopinath KS, Jaques DP, Gerold FP, Strong EW. Analysis of prognostic variables and results after vertical partial laryngectomy. The American Journal of Surgery 1988;156:264-268.

Soskolne CL, Zeighami EA, Hanis NM, Kupper LL, Herrmann N, Amsel J et al. Laryngeal cancer and occupational exposure to sulfuric acid. American Journal of Epidemiology 1984;120(3):358-369.

Terhaard CHJ, Hordijk GJ, Van Den Broek P, De Jong PC, Snow GB, Hilgers FJM et al. T3 laryngeal cancer: a
    retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clinical
    Otolaryngology 1992;17:393-402.

Thomas JV, Olsen KD, Neel HB, DeSanto LW, Suman VJ. Early glottic carcinoma treated with open laryngeal procedures.
    Archives of Otolaryngology Head and Neck Surgery 1994;120:264-268.

U.S. Department of Health and Human Services. What you need to know about cancer of the larynx.  NIH Publication
    No. 89-1568; 1988.

Vázquez Calzada JL. La población de Puerto Rico y su trayectoria  histórica, Río Piedras: Raga Offset Printing Service;

Vermund H, Boysen M, Brandenburg JH, Evensen J, Jacobsen AB, Kaalhus O et al. Primary irradiation, surgery or combined
    therapy in squamous cell carcinoma of the larynx.  A comparison of treatment results from two centers. Acta Oncologica

Viani L, Stell PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer 1991;67:577-584.

Whelan SL, Parkin PM, Masuyer E, editors. Patterns of Cancer in Five Continents No. 102. Lyon: WHO IARC, 1990.

Wolf GT, Hong WK, Fisher SG, Urba S, Endicott JW, Close Let al. Induction chemotherapy plus radiation compared with
    surgery plus radiation in patients with advanced laryngeal cancer. New England Journal of Medicine

Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy
    and radiation are used for organ preservation. Laryngoscope 1992;102:934-939.

World Health Organization. International Classification of Diseases. 9th Revision. Clinical Modification (ICD-9-CM).
    Ann Arbor: Edward Brothers, Inc.; 1986:Volume 1.

Wynder EL, Covey LS, Mabuchi K, Mushinski M. Environmental risk factors in cancer of the larynx, a second look. Cancer
    1976;38: 1591-1601.

Young JL, Asire AJ, Pollcell ES. SEER Program: Cancer Incidence and Mortality in the United States 1973-1976.
    DHEW Publication No. (NIH)78-1837. Washington, D.C.: U.S. Government Printing Office; 1978.

Zagraniski RT, Kelsey JL, Walter SD. Occupational risk factors for laryngeal carcinoma: Connecticut, 1975-1980. American
    Journal of Epidemiology 1986;124(1):67-76.

Zamora RL, Harvey JE, Sessions DG, Spitznagel EL. Clinical staging for primary malignancies of the supraglottic larynx.
    Laryngoscope 1993;103:69-77.

[Pág. Anterior]